Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
111 hedge funds and large institutions have $123M invested in Enzo Biochem, Inc. in 2016 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 11 closing their positions.
831% more call options, than puts
Call options by funds: $512K | Put options by funds: $55K
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
19% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 32
7% more funds holding
Funds holding: 104 → 111 (+7)
1.03% less ownership
Funds ownership: 53.28% → 52.25% (-1%)
16% less capital invested
Capital invested by funds: $147M → $123M (-$24.1M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Globeflex Capital
San Diego,
California
|
+$1.35M |
| 2 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$1.03M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$784K |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$645K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$560K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$2.7M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$1.89M |
| 3 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
-$1.64M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$829K |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$788K |
ENZ Hedge Fund Activity: Q3 2016 in Review
111 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2016, worth a combined $123M — down 16% from $147M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ENZ positions and 11 closed out — a net gain of 7 holders — while 38 added to existing stakes and 32 trimmed.
The largest buyer was Globeflex Capital, opening a new position worth an estimated $1.35M. The largest seller was Kopp Investment Advisors, cutting an estimated $2.7M.
- 111 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2016, up from 104 in Q2 2016.
- Funds reported $123M of Enzo Biochem, Inc. stock for Q3 2016, down 16% quarter-over-quarter.
- 18 funds opened new Enzo Biochem, Inc. positions in Q3 2016 and 11 closed out, a net change of +7 holders.
- The largest Enzo Biochem, Inc. buyer in Q3 2016 was Globeflex Capital, an estimated $1.35M added.
- The largest Enzo Biochem, Inc. seller in Q3 2016 was Kopp Investment Advisors, an estimated $2.7M sold.
Based on aggregated 13F filings for Q3 2016.